Waiting time for breast cancer treatment in Alberta

Canadian Journal of Public Health

Volumn 95, Issue 5, 2004, Pages 341-345

  Reed, Alyssa D ^a,c   Williams, Robert J ^a   Wall, Patricia A ^a   Hasselback, Paul ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Interior Health Authority   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; BREAST SURGERY; CANADA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER THERAPY; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEALTH SERVICE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE REGRESSION; PATIENT REFERRAL; PREDICTION; STATISTICAL SIGNIFICANCE; TIME;

EID: 4944249419     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03405142     Document Type: Article

References (47)

1. Canadian Cancer Statistics 2002. Toronto: National Cancer Institute of Canada. 2002. Available on-line at: www.cancer.ca/stats (accessed 2003 Jan 13).
2. Caplan LS, Helzlsouer K. Delay in breast cancer: A review of the literature. Public Health Rev 1992/93;20:187-214.
3. Canadian Society for Surgical Oncology position statement. Available on-line at: www.cos.ca/csso/policy.htm (accessed 2003 Jan 27).
4. O'Mahoney M. Women's lived experience of breast biopsy: A phenomenological study. J Clin Nurs 2001;10:512-20.
5. Padgett DK, Yedidia M, Kerner, J, Mandelblatt J. The emotional consequences of false positive mammography: African-American women's reactions in their own words. Women & Health 2001;33:1-14.
6. Olivotto IA, Bancej C, Goel V, Snider J, McAuley G, Irvine B, et al. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ 2001;165:277-83.
7. Gaudine A, Sturge-Jacobs M, Kennedy M. The experience of waiting and life during breast cancer survivors. Res Theory Nurs Pract 2003;17:153-68.
8. Poole K, Lyne P. The 'cues' to diagnosis: Describing the monitoring activities of women undergoing diagnostic investigations for breast disease. J Adv Nurs 2000;31:200-8.
9. Elwood MJ, Moorehead W. Delay in diagnosis and long-term survival in breast cancer. BMJ 1980;280:1291-94.
10. Feldman JG, Saunders M, Carter A, Gardner B. The effects of patient delay and symptoms other than a lump on survival in breast cancer. Cancer 1983;51:1226-29.
11. Charlson ME. Delay in the treatment of carcinoma of the breast. Surgery, Gynecology and Obstetrics 1985;160:393-99.
12. Vernon SW, Tilley B, Neale V, Steinfeldt L. Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer 1985;55:1563-71.
13. Hainsworth PJ, Henderson M, Bennett R. Delayed presentation in breast cancer: Relationship to tumour stage and survival. Breast J 1993;2:37-41.
14. Huguley CM, Brown R, Greenberg R, Clark S. Breast self-examination and survival from breast cancer. Cancer 1988;62:1389-96.
15. Rossi S, Cinini C, Pietro C, Lombardi C, Crucitti A, Bellantone R, Crucitti F. Diagnostic delay in breast cancer: Correlation with disease stage and prognosis. Tumouri 1990;76:559-62.
16. Rabinovich MG, Vallejo C, Perez J, Rodriguez R, Cuevas M, Machiavelli M, et al. Impact of delay to treatment upon survival in 1067 patients with breast cancer. Int J Oncology 1993;2:197-201.
17. Afzelius P, Zedeler K, Sommer H, Mourdsen H, Blichert-Toft M. Patient's and doctor's delay in primary breast cancer. Acta Oncol 1994;33:345-51.
18. Raabe NK, Fossaa S. Primary invasive breast carcinoma in Oslo 1980-1989. Acta Oncol 1996;35:9-15.
19. Richards MA, Wetscombe A, Love S, Littlejohns P, Ramirez A. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet 1999;353:1119-26.
20. Richards MA, Smith P, Ramirez A, Fentiman I, Rubens R. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999;79:858-64.
21. Wyatt RM, Beddoe A, Dale R. The effects of delays in radiotherapy treatment on tumour control. Phys Med Biol 2003;48:139-55.
22. Alderson MR, Hamlin I, Staunton M. The relative significance of prognostic factors in breast carcinoma. Br J Cancer 1971;25:646-56.
23. Dennis CR, Gardner B, Lim B. Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer 1975;35:714-20.
24. Wallgren A, Silfversward C, Eklund G. Prognostic factors in mammary carcinoma. Acta Radiol 1976;15:1-15.
25. Fisher ER, Redmond C, Fisher B. A perspective concerning the relationship of duration of symptoms to treatment failure in patients with breast cancer. Cancer 1977;40:3160-67.
26. Neave LM, Mason B, Kay R. Does delay in diagnosis of breast cancer affect survival? Breast Cancer Res Treat 1990;15:103-8.
27. Goodwin JS, Samet J, Hunt W. Determinants of survival in older cancer patients. J Natl Cancer Inst 1996;88:1031-38.
28. Sainsbury R, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: A retrospective analysis. Lancet 1999;353:1132-35.
29. Spurgeon P, Barwell F, Kerr D. Waiting times for cancer patients in England after general practitioners' referrals: Retrospective national survey. BMJ 2000;230:838-39.
30. Robinson D, Bell C, Moller H, Basnett I. Effect of the UK government's 2-week target on waiting times in women with breast cancer in southeast England. Br J Cancer 2003;89:492-96.
31. Khawaja A, Allan S. Has the breast cancer 'two week wait' guarantee for assessment made any difference? Eur J Surg Oncology 2000;26:536-39.
32. Mackillop WJ, Fu H, Quirt C, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys 1994;30:221-28.
33. Mayo NE, Scott S, Shen N, Hanley J, Goldberg M, MacDonald N. Waiting time for breast cancer surgery in Quebec. CMAJ 2001;164:1132-38.
34. Simunovic M, Gagliardi A, McCready D, Coates A, Levine M, DePetrillo D. A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario. CMAJ 2001;165:421-25.
35. Caplan LS, May D, Richardson L. Time to diagnosis and treatment of breast cancer: Results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health 2000;90:130-34.
36. Burgess CC, Ramirez A, Richards M, Love S. Who and what influences delayed presentation in breast cancer? Br J Cancer 1998;77:1343-48.
37. Caplan LS, Helzlsouer K, Shapiro S, Freedman L, Coates R, Edwards B. System delay in breast cancer in Whites and Blacks. Am J Epidemiol 1995;142:804-12.
38. Finley ML, Francis A. Risk factors and physician delay in the diagnosis of breast cancer. Prog Clin Biol Res 1983;130:351-60.
39. Nichols S, Waters W, Fraser M, Wheeler M, Ingham S. Delay in the presentation of breast symptoms for consultant investigation. Comm Med 1981;3:217-25.
40. Adam SA, Horner J, Vessey M. Delay in treatment for breast cancer. Comm Med 1980;2:195-201.
41. MacArthur C, Smith A. Delay in breast cancer and the nature of presenting symptoms. Lancet 1981;1:601-3.
42. Bywaters JL. The incidence and management of female breast disease in a general prantice. J R Coll General Practitioners 1977;27:353-57.
43. Greer S. Psychological aspects: Delay in the treatment of breast cancer. Proceeding R Soc Med 1974;67:470-72.
44. North American Association of Central Cancer Registries. Available on-line at http://www.naaccr.org/.
45. Alberta Cancer Registry: Annual Report of Cancer Statistics, 1997-99. Alberta Cancer Board. 2002. Available on-line at http://www.cancerboard.ab.ca/cancer/cancer_online.html (accessed 2003 Aug 28).
46. Health Canada. Canada Health Act Annual Report, 2001-2002. Ottawa, ON: Author.
47. College of Physicians and Surgeons of Alberta. Physician Resource Statistics. Available on-line at http://www.cpsa.ab.ca/physicianregistration/physician_statistics.asp.